Investing.com - Financial Markets Worldwide
Final hours! Save up to 55% OFF InvestingProCLAIM SALE

Stocks - Tesla, BAT, Newmont Rise in Premarket; Incyte Falls

Published 01/03/2020, 08:49 AM
Updated 01/03/2020, 08:51 AM
© Reuters.
CVX
-
BATS
-
XOM
-
COP
-
OXY
-
NEM
-
DVN
-
TSLA
-
INCY
-
ANET
-

Investing.com -- Stocks in focus in premarket trade on Thursday, 3rd January.

  • Tesla (NASDAQ:TSLA) stock rose 1.7% after the company reported it shipped a record 112,000 vehicles in the three months through December, 6,000 more than Wall Street forecasts. As such, it delivered roughly 367,500 cars last year, a 50% increase from 2018.

  • Incyte (NASDAQ:INCY) stock fell 10.4% after the biopharma company said after the bell on Thursday that its itacitinib drug had failed a late-stage clinical trial. The drug was intended for use in combination with corticosteroids to treat patients whose bodies reject transplanted bone marrow or stem cells.

    • Newmont Goldcorp (NYSE:NEM) stock rose 1.8%, shadowing the rally in the precious metal after a U.S. airstrike killed an Iranian general, triggering a flight to haven assets in markets worldwide.

  • Oil producers broadly rose in reaction to the spike in crude prices after the U.S. airstrike. Devon Energy (NYSE:DVN) rose 3.0%, Occidental Petroleum (NYSE:OXY) rose 2.7%, ConocoPhillips (NYSE:COP) rose 1.6% and Exxon Mobil (NYSE:XOM) rose 1.0%. Chevron (NYSE:CVX) rose 0.7%.

    • Arista Networks (NYSE:ANET) fell 1.4% after it announced the departure of its chief customer officer late on Thursday.

  • British American Tobacco (LON:BATS) ADRs rose 2.2% after the company said it will file applications for regulatory approval of all its vaping products by the FDA’s May 12 deadline.

    Latest comments

    Install Our App
    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.